Per Jr. Greisen

Company: Novo Nordisk

Job title: Director

Seminars:

Acclerating AI and Data-driven Design of Biologics to Untap Novel Biotherapeutics 3:45 am

Examining best-practices for data-driven design of biologics by showcasing the optimization of a bispecific antibody How can we best leverage AI to design novel biotherapeutics? What the future hold for biologics in the age of AI?Read more

day: Day Two

Panel Discussion: Facilitating End-To-End Integration of AI from Early Biologic Discovery to Late Development 2:30 pm

Examining common challenges for end-to-end integration of AI within your organisations How can we foster collaboration between different departments, including research, development, and CMC, and establish AI as a core organisational discipline? What are the best-practices for incorporating integrated platforms for predictive models for from discovery to development?Read more

day: Day Two